Outset Medical, Inc. (OM) Research

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

Market snapshot

Symbol
OM
Price
$5.05
Day change
+25.62%
Market cap
$93.6M
P/E ratio
-1.24x
52-week range
3-21.36
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$11.50

Peer companies

  • Perspective Therapeutics, Inc. (CATX)
  • Solana Company (HSDT)
  • Inogen, Inc. (INGN)
  • Nano-X Imaging Ltd. (NNOX)
  • Owens & Minor, Inc. (OMI)
  • Quanterix Corporation (QTRX)
  • Shoulder Innovations, Inc. (SI)
  • SANUWAVE Health, Inc. (SNWV)

Recent insider activity

  • HACKETT PATRICK T — A-Award (10667 shares) on 2026-06-04
  • OBOYLE KEVIN C — A-Award (10667 shares) on 2026-06-04
  • Prange Karen — A-Award (10667 shares) on 2026-06-04
  • LANG BRENT D. — A-Award (10667 shares) on 2026-06-04
  • GROSSMAN D KEITH — A-Award (10667 shares) on 2026-06-04

Open Outset Medical, Inc. (OM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.